249 related articles for article (PubMed ID: 25662545)
1. Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint.
Damlar I; Esen E; Tatli U
Med Oral Patol Oral Cir Bucal; 2015 May; 20(3):e278-83. PubMed ID: 25662545
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Effect of Glucosamine-Chondroitin Sulfate, Tramadol, and Sodium Hyaluronic Acid on Expression of Cytokine Levels in Internal Derangement of Temporomandibular Joint.
Ganti S; Shriram P; Ansari AS; Kapadia JM; Azad A; Dubey A
J Contemp Dent Pract; 2018 Dec; 19(12):1501-1505. PubMed ID: 30713180
[TBL] [Abstract][Full Text] [Related]
3. Cytokines in healthy temporomandibular joint synovial fluid.
Kristensen KD; Alstergren P; Stoustrup P; Küseler A; Herlin T; Pedersen TK
J Oral Rehabil; 2014 Apr; 41(4):250-6. PubMed ID: 24575711
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the cytokine profiles of the synovial fluid in a normal temporomandibular joint: preliminary study.
Kim YK; Kim SG; Kim BS; Lee JY; Yun PY; Bae JH; Oh JS; Ahn JM; Kim JS; Lee SY
J Craniomaxillofac Surg; 2012 Dec; 40(8):e337-41. PubMed ID: 22425498
[TBL] [Abstract][Full Text] [Related]
5. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Morin P; Bratt J
Cells Tissues Organs; 2005; 180(1):22-30. PubMed ID: 16088130
[TBL] [Abstract][Full Text] [Related]
6. Intra-articular levels of prostaglandin E2, hyaluronic acid, and chondroitin-4 and -6 sulfates in the temporomandibular joint synovial fluid of patients with internal derangement.
Murakami KI; Shibata T; Kubota E; Maeda H
J Oral Maxillofac Surg; 1998 Feb; 56(2):199-203. PubMed ID: 9461145
[TBL] [Abstract][Full Text] [Related]
7. Does joint effusion on T2 magnetic resonance images reflect synovitis? Part 2. Comparison of concentration levels of proinflammatory cytokines and total protein in synovial fluid of the temporomandibular joint with internal derangements and osteoarthrosis.
Segami N; Miyamaru M; Nishimura M; Suzuki T; Kaneyama K; Murakami K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Oct; 94(4):515-21. PubMed ID: 12374930
[TBL] [Abstract][Full Text] [Related]
8. Glucosamine oral administration as an adjunct to hyaluronic acid injection in treating temporomandibular joint osteoarthritis.
Cen X; Liu Y; Wang S; Yang X; Shi Z; Liang X
Oral Dis; 2018 Apr; 24(3):404-411. PubMed ID: 28862770
[TBL] [Abstract][Full Text] [Related]
9. Correlation of inflammatory cytokines with arthroscopic findings in patients with temporomandibular joint internal derangements.
Sandler NA; Buckley MJ; Cillo JE; Braun TW
J Oral Maxillofac Surg; 1998 May; 56(5):534-43; discussion 543-4. PubMed ID: 9590334
[TBL] [Abstract][Full Text] [Related]
10. Effects of an oral administration of glucosamine-chondroitin-quercetin glucoside on the synovial fluid properties in patients with osteoarthritis and rheumatoid arthritis.
Matsuno H; Nakamura H; Katayama K; Hayashi S; Kano S; Yudoh K; Kiso Y
Biosci Biotechnol Biochem; 2009 Feb; 73(2):288-92. PubMed ID: 19202302
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis.
Gulen H; Ataoglu H; Haliloglu S; Isik K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):e1-4. PubMed ID: 19426899
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor mediates temporomandibular joint bone tissue resorption in rheumatoid arthritis.
Ahmed N; Petersson A; Catrina AI; Mustafa H; Alstergren P
Acta Odontol Scand; 2015 Apr; 73(3):232-40. PubMed ID: 25515682
[TBL] [Abstract][Full Text] [Related]
13. The impact of arthrocentesis with and without hyaluronic acid injection in the prognosis and synovial fluid myeloperoxidase levels of patients with painful symptomatic internal derangement of temporomandibular joint: a randomised controlled clinical trial.
Ozdamar SM; Alev B; Yarat A
J Oral Rehabil; 2017 Feb; 44(2):73-80. PubMed ID: 27973684
[TBL] [Abstract][Full Text] [Related]
14. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders.
Kaneyama K; Segami N; Sun W; Sato J; Fujimura K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Mar; 99(3):276-84. PubMed ID: 15716832
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders.
Alstergren P; Kopp S
J Oral Maxillofac Surg; 2000 Feb; 58(2):180-6; discussion 186-8. PubMed ID: 10670597
[TBL] [Abstract][Full Text] [Related]
16. Relationship of synovial tumor necrosis factor alpha and interleukin 6 to temporomandibular disorder.
Lee JK; Cho YS; Song SI
J Oral Maxillofac Surg; 2010 May; 68(5):1064-8. PubMed ID: 20031289
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain.
Nordahl S; Alstergren P; Kopp S
J Oral Maxillofac Surg; 2000 May; 58(5):525-30. PubMed ID: 10800908
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study.
Nguyen P; Mohamed SE; Gardiner D; Salinas T
Cranio; 2001 Apr; 19(2):130-9. PubMed ID: 11842864
[TBL] [Abstract][Full Text] [Related]
19. Temporomandibular joint pain: relationship to internal derangement type, osteoarthrosis, and synovial fluid mediator level of tumor necrosis factor-alpha.
Emshoff R; Puffer P; Rudisch A; Gassner R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Oct; 90(4):442-9. PubMed ID: 11027380
[TBL] [Abstract][Full Text] [Related]
20. Deficient cytokine control modulates temporomandibular joint pain in rheumatoid arthritis.
Ahmed N; Catrina AI; Alyamani AO; Mustafa H; Alstergren P
Eur J Oral Sci; 2015 Aug; 123(4):235-41. PubMed ID: 26010823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
